SOX2 and triple-negative breast carcinoma: For example, triple-negative breast cancers (TNBC) exhibit enhanced epithelial-mesenchymal transition (EMT), increased expression of SOX2 and CXCR4, and an ability to cross the blood–brain barrier, contributing to their high affinity for brain tissue12.